News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PX’Therapeutics Announces EuroNeut-41 Prophylactic HIV Vaccine Clinical Trial


3/13/2012 6:25:33 AM

GRENOBLE, France--(BUSINESS WIRE)--PX’Therapeutics is pleased to announce the launching of a Phase 1 clinical trial of a prophylactic vaccine against HIV entitled: “Phase 1, Randomised, Single-centre, Observer-blind Clinical Trial of Safety and Immunogenicity of Nasal-prime and Intramuscular Boost Immunisation With EN41-FPA2 HIV Vaccine in Healthy Female Volunteers.”

Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES